2019 Speakers

European Antibody Congress Provisionally Confirmed Speakers

Alain Beck, Senior Director, NBEs Analytical Chemistry , Pierre Fabre
Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute, A* Star
Andrea Marschall, Post-Doc , Brandeis University
Anne Kvarnhammar, Senior Scientist, Alligator Bioscience
Armin Sepp, Scientific Leader and GSK Associate Fellow, GSK
Baolin Zhang, Senior Investigator, Lead Product Reviewer, Office of Biotechnology Products, FDA CDER
Chris Lloyd, Senior Scientist, Protein Engineering, Antibody Discovery and Protein Engineering, MedImmune
Christoph Merten, Group Leader, Microfluidics , European Molecular Biology Laboratory (EMBL)
Christoph Roesli, Senior Fellow, Global Drug Development, Novartis
Claire Dobson, Director, Antibody Discovery & Protein Engineering, MedImmune
Colette Johnson, Senior Director, Early Discovery, Crescendo Biologics
Fabian Richter, Post-Doc, Biomedical Engineering, University of Stuttgart
Frank Stenner, Professor of Medicine, Dep. of Oncology, Head of the Centre of Hemato Oncology, USB
Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office
Helene Kaplon, Post-Doctoral Fellow, Servier
Jiri Kovarik, Research Investigator, Novartis
Johan Nilvebrant, Researcher  
John Delaney, Executive Director of Research, Amgen
Jonny Finlay, CEO, Ultrahuman
Keno Gutierrez, Investment Director, M Ventures
Kevin Johnson, Partner, Medicxi
Krzysztof Masternak, Head of Biology, Novimmune
Megan (Zhaoyang) Li, Senior Director, Clinical Pharmacology, Shire
Michael Hust, Group Leader, University of Braunschweig
Patrick Garidel, Head of Process, Purification and Pharma Development, Boehringer Ingelheim
Pawel Stocki, Senior Principal Scientist, Ossianix
Philipp Spycher, PSI Founder Fellow, Paul Scherrer Institut
Rita Martello, Laboratory Head, Bioanalysis, Sanofi
Roger Beerli, Chief Scientific Officer, NBE Therapeutics
Stefan Zielonka, Associate Director, Merck
Thomas Nittoli, Director of R&D Chemistry, Regeneron
Thomas Pillow, Senior Scientist, Genentech
Thorsten Schmidt, Head of Biologics Research, R&D, Sanofi
Ulf Grawunder, Chief Executive Officer, NBE therapeutics
Vijay Chudasama, Lecturer, Chemistry, UCL
Wouter Verdurmen, Assistant Professor, Radboud University Medical Center
Vladka Curin, Head of R&D, Blood Transfusion Centre of Slovenia
 
 

Immunotherapy Provisionally Confirmed Speakers

Lamine Mbow, Senior Vice President and Head, Glenmark Pharma
Dario Neri, Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
Agnete Frederiksen, President and Chief Scientific Officer, Vaccibody
Ahuva Nissim, Professor, William Harvey Research Institute, Queen Mary University
Alan Smith, Executive Vice President, Technical Operations, Bellicum
Andreas Katopodis, CEO, Anaveon
Bernard Vanhove, C hief Operating Officer, Director of R&D and International Scientific Collaborations, OSE ImmunoTherapeutics
Brian Champion, Chief Scientific Officer, Psioxus
Damian Page, Medical Leader, Personalised Health, Roche
Eric Halioua, President and CEO, PDC*line Pharma
Frederic Triebel, Chief Scientific Officer, Chief Medical Officer, Immutep
Heinz Laubli, Attending Physician, Medical Oncology, University Hospital Basel
Mark Mamula, Professor, Yale
Michelle Rosenzwajg, Head, Immunomonitoring Team,
Nabila Seddiki, Senior Lecturer, INSERM
Oliver Hill, Vice President, Molecular Biology, Apogenix
Phil Bland-Ward, CSO, Crescendo Biologics
Rony Dahan, Assistant Professor, Department of Immunology Weizmann Institute
Shane Olwill, Head of Immuno-Oncology, Pieris Pharma
Thomas Hach, Director, Healthcare Systems, Novartis
Tim Fugmann, Head of Precision Medicine, Philochem
 
 

Biosimilars Provisionally Confirmed Speakers

Adam Levysohn , Sr Director Market Access Biosimilar, Biogen
Aidan Fry, Editor, Generics bulletin
Alain Beck , Senior Director, Biologics CMC & developability, CIPF and Associate Editor, mAbs
Alvin Luk , Senior Vice President & Chief Medical Officer, Shanghai Henlius
Annick de Vries, Director Bioanalysis, Sanquin
Brenda Rascon , Director Regulatory Affairs, Cinfa Biotech GmbH
Hanadi Nahas , Head of Market Access & Health policy department, Mersaco SAL
Jonathan Underhill , Medicines Clinical Adviser, Medicines and Technologies Programme (MTP), NICE
Karsten Roth , Director Clinical Operations and Pharmacovigilance, Cinfa Biotech GmbH
Kaustubh Berde , Vice President, Emerging Markets – Formulations & Biotech formulations & API division, Wockhardt Limited
Meenu Wadhwa , Section Leader for Cyotkines and Growth Factors Section, NIBSC
Paul Harmon , Sr. Director, Biologics, Mylan
Roman Drai, R&D Director, GEROPHARM
Sarfaraz Niazi , Chairman, Professor, Karyo Biologics/University of Illinois
 
 

Clinical Trials Provisionally Confirmed Speakers

Andy Lee , Head of Global Clinical Trial Operations, MSD
Thomas Thoma , Head of Clinical Trials Supply, Teva Europe